Diabetic Macular Edema Treated With Ozurdex (DMEO)
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2016
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Pharmacodynamics
- Acronyms DMEO
- 10 Jun 2017 Biomarkers information updated
- 20 Jun 2016 Status changed from active, no longer recruiting to completed.
- 15 Dec 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.